Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Sue Griffin

Concepts (57)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Alzheimer Disease
6
2013
317
1.200
Why?
Epilepsy
3
2013
174
0.760
Why?
Neuroimmunomodulation
1
2013
14
0.450
Why?
Temporal Lobe
1
2013
70
0.440
Why?
Apolipoproteins E
1
2013
56
0.430
Why?
Apolipoprotein E3
1
2012
8
0.420
Why?
Neurons
2
2012
459
0.360
Why?
Aspartic Acid Endopeptidases
1
2010
16
0.360
Why?
Amyloid Precursor Protein Secretases
1
2010
12
0.360
Why?
Amyloid beta-Protein Precursor
1
2010
23
0.350
Why?
Endosomes
1
2010
30
0.350
Why?
Apolipoprotein E4
1
2009
19
0.340
Why?
Peptide Fragments
1
2010
216
0.330
Why?
Receptors, Tumor Necrosis Factor
1
2008
36
0.310
Why?
Immunoglobulin G
1
2008
186
0.290
Why?
Microglia
2
2006
141
0.280
Why?
Depressive Disorder
1
2009
339
0.280
Why?
Drug Delivery Systems
1
2008
136
0.270
Why?
Interleukin-1
2
2006
104
0.270
Why?
Inflammation
1
2006
604
0.200
Why?
Down Syndrome
3
2010
91
0.190
Why?
Aging
1
2006
688
0.190
Why?
Aged
5
2013
9272
0.160
Why?
Brain
1
2006
1309
0.150
Why?
Amyloid beta-Peptides
2
2010
69
0.140
Why?
Infant
2
2013
3551
0.120
Why?
Child, Preschool
2
2013
3853
0.120
Why?
Young Adult
2
2013
3936
0.110
Why?
Neuroglia
1
2012
43
0.100
Why?
Genotype
1
2013
538
0.100
Why?
Humans
7
2013
49827
0.100
Why?
Alleles
1
2012
251
0.100
Why?
Adolescent
2
2013
6340
0.100
Why?
Middle Aged
3
2013
11997
0.090
Why?
Blotting, Western
1
2012
602
0.090
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2012
595
0.090
Why?
Child
2
2013
6824
0.090
Why?
Adult
3
2013
13160
0.090
Why?
Immunohistochemistry
1
2012
971
0.080
Why?
Injections, Spinal
1
2008
19
0.080
Why?
Gene Expression Profiling
1
2012
1031
0.070
Why?
Female
3
2013
26329
0.070
Why?
Nerve Growth Factors
1
2006
27
0.070
Why?
S100 Proteins
1
2006
34
0.070
Why?
Tumor Necrosis Factor-alpha
1
2008
388
0.070
Why?
Male
2
2013
25093
0.050
Why?
Neurofibrillary Tangles
1
2002
4
0.050
Why?
Plaque, Amyloid
1
2002
15
0.050
Why?
Nerve Degeneration
1
2002
24
0.050
Why?
Age of Onset
1
2002
106
0.050
Why?
Aged, 80 and over
1
2009
3125
0.050
Why?
Polymorphism, Genetic
1
2002
181
0.050
Why?
Brain Injuries
1
2002
160
0.050
Why?
Astrocytes
1
2002
145
0.050
Why?
Nerve Tissue Proteins
1
2002
193
0.050
Why?
Disease Progression
1
2002
822
0.040
Why?
Genetic Predisposition to Disease
1
2002
510
0.040
Why?
Griffin's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description